Metraipolis › archive › dc_b7731ab5cfcf
Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42375370
- DOI
- 10.3389/fimmu.2026.1831234
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:48:08.105Z
- SHA-256 of the archived text
5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c- Stable URL of this page
https://metraipolis.com/documento/dc_b7731ab5cfcf
How to cite
Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370 — Europe PMC (en), https://europepmc.org/article/MED/42375370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b7731ab5cfcf (Metraipolis archive dc_b7731ab5cfcf, sha256 5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c)
BibTeX
@misc{dcb7731ab5cfcf,
title = {Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42375370},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b7731ab5cfcf; sha256 5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42375370. Agents can read the archived copy with the MCP tool read_document.